A common goal to CARE: Cancer Advocates, Researchers, and Clinicians Explore current treatments and clinical trials for breast cancer brain metastases

por Natalie S. Joe, Christine Hodgdon, Lianne Kraemer, Kristin J. Redmond, Vered Stearns, Daniele M. Gilkes
Publicado 2021

Bevacizumab improves tumor infiltration of mature dendritic cells and effector T-cells in triple-negative breast cancer patients

por Yves Boucher, Ashwin S. Kumar, Jessica M. Posada, Evisa Gjini, Kathleen Pfaff, Mikel Lipschitz, Ana Lako, Dan G. Duda, Scott J. Rodig, F. Stephen Hodi, Rakesh K. Jain
Publicado 2021

A subset of lung cancer cases shows robust signs of homologous recombination deficiency associated genomic mutational signatures

por Miklos Diossy, Zsofia Sztupinszki, Judit Borcsok, Marcin Krzystanek, Viktoria Tisza, Sandor Spisak, Orsolya Rusz, Jozsef Timar, István Csabai, Janos Fillinger, Judit Moldvay, Anders Gorm Pedersen, David Szuts, Zoltan Szallasi
Publicado 2021

Circulating tumor cell heterogeneity in neuroendocrine prostate cancer by single cell copy number analysis

por Vincenza Conteduca, Sheng-Yu Ku, Luisa Fernandez, Angel Dago-Rodriquez, Jerry Lee, Adam Jendrisak, Megan Slade, Cole Gilbertson, Jyothi Manohar, Michael Sigouros, Yipeng Wang, Ryan Dittamore, Rick Wenstrup, Juan Miguel Mosquera, Joseph D. Schonhoft, Himisha Beltran
Publicado 2021

Giant-neglected facial Marjolin’s ulcer associated with perioperative blood loss anemia

por Ahmad Kaako, Ratna M Malkan, Cassidy P Goff
Publicado 2020

Treatment scheduling effects on the evolution of drug resistance in heterogeneous cancer cell populations

por Gauri A. Patwardhan, Michal Marczyk, Vikram B. Wali, David F. Stern, Lajos Pusztai, Christos Hatzis
Publicado 2021

Neratinib plus trastuzumab is superior to pertuzumab plus trastuzumab in HER2-positive breast cancer xenograft models

por Jamunarani Veeraraghavan, Carolina Gutierrez, Vidyalakshmi Sethunath, Sepideh Mehravaran, Mario Giuliano, Martin J. Shea, Tamika Mitchell, Tao Wang, Sarmistha Nanda, Resel Pereira, Robert Davis, Kristina Goutsouliak, Lanfang Qin, Carmine De Angelis, Irmina Diala, Alshad S. Lalani, Chandandeep Nagi, Susan G. Hilsenbeck, Mothaffar F. Rimawi, C. Kent Osborne, Rachel Schiff
Publicado 2021

Mutated clones driving leukemic transformation are already detectable at the single-cell level in CD34-positive cells in the chronic phase of primary myelofibrosis

por Sandra Parenti, Sebastiano Rontauroli, Chiara Carretta, Selene Mallia, Elena Genovese, Chiara Chiereghin, Clelia Peano, Lara Tavernari, Elisa Bianchi, Sebastian Fantini, Stefano Sartini, Oriana Romano, Silvio Bicciato, Enrico Tagliafico, Matteo Della Porta, Rossella Manfredini
Publicado 2021

The Aurora kinase/β-catenin axis contributes to dexamethasone resistance in leukemia

por Kinjal Shah, Mehreen Ahmed, Julhash U. Kazi
Publicado 2021

The temporal mutational and immune tumour microenvironment remodelling of HER2-negative primary breast cancers

por Leticia De Mattos-Arruda, Javier Cortes, Juan Blanco-Heredia, Daniel G. Tiezzi, Guillermo Villacampa, Samuel Gonçalves-Ribeiro, Laia Paré, Carla Anjos Souza, Vanesa Ortega, Stephen-John Sammut, Pol Cusco, Roberta Fasani, Suet-Feung Chin, Jose Perez-Garcia, Rodrigo Dienstmann, Paolo Nuciforo, Patricia Villagrasa, Isabel T. Rubio, Aleix Prat, Carlos Caldas
Publicado 2021

Overweight and prognosis in triple-negative breast cancer patients: a systematic review and meta-analysis

por Sixten Harborg, Robert Zachariae, Julia Olsen, Maja Johannsen, Deirdre Cronin-Fenton, Henrik Bøggild, Signe Borgquist
Publicado 2021

Genomic characterization and outcome evaluation of kinome fusions in lung cancer revealed novel druggable fusions

por Binghao Li, Hao Qu, Jing Zhang, Weibo Pan, Meng Liu, Xiaobo Yan, Xin Huang, Xuexin He, Dong Lin, Sisi Liu, Ruting Guan, Yong Wu, Qiuxiang Ou, Hua Bao, Youbin Xu, Xue Wu, Yang Shao, Nong Lin
Publicado 2021

Multiscale-omic assessment of EWSR1-NFATc2 fusion positive sarcomas identifies the mTOR pathway as a potential therapeutic target

por Nathan D. Seligson, Richard D. Maradiaga, Colin M. Stets, Howard M. Katzenstein, Sherri Z. Millis, Alan Rogers, John L. Hays, James L. Chen
Publicado 2021

Knockout of immunotherapy prognostic marker genes eliminates the effect of the anti-PD-1 treatment

por Naixue Yang, Fansen Ji, Liqing Cheng, Jingzhe Lu, Xiaofeng Sun, Xin Lin, Xun Lan
Publicado 2021

First-line treatment of advanced ALK-positive non-small-cell lung cancer

por Gandhi S, Chen H, Zhao Y, Dy GK
Publicado 2015

Update on biomarkers for the detection of lung cancer

por Jantus-Lewintre E, Usó M, Sanmartín E, Camps C
Publicado 2012

Challenges in the development of future treatments for breast cancer stem cells

por Shyam A Patel, Anicia Ndabahaliye, Philip K Lim, et al
Publicado 2010

The evaluation of older patients with cervical cancer

por Gao Y, Ma JL, Gao F, Song LP
Publicado 2013

Single nucleotide polymorphisms as susceptibility, prognostic, and therapeutic markers of nonsmall cell lung cancer

por Zienolddiny S, Skaug V
Publicado 2011

Oseltamivir phosphate monotherapy ablates tumor neovascularization, growth, and metastasis in mouse model of human triple-negative breast adenocarcinoma

por Haxho F, Allison S, Alghamdi F, Brodhagen L, Kuta VE, Abdulkhalek S, Neufeld RJ, Szewczuk MR
Publicado 2014